Showing items 101–146
Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen…
Grant US-10253100-B2
United States of America
ANTIBODIES TO M(H)DM2/4 AND THEIR USE IN DIAGNOSING AND TREATING CANCER
Application WO-2019023460-A1
World Intellectual Property Organisation (WIPO)
Anti-human interleukin-1 receptor accessory protein antibody and its use for treating…
Grant US-10100119-B2
United States of America
PD-L1 AND TA-MUC1 ANTIBODIES
Application WO-2018178122-A1
World Intellectual Property Organisation (WIPO)
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
Grant US-10000560-B2
United States of America
COMBINATION OF T-CELL REDIRECTING MULTIFUNCTIONAL ANTIBODIES WITH IMMUNE CHECKPOINT…
Application WO-2018099978-A1
World Intellectual Property Organisation (WIPO)
COMBINATION OF T-CELL REDIRECTING MULTIFUNCTIONAL ANTIBODIES WITH IMMUNE CHECKPOINT…
Application WO-2018099539-A1
World Intellectual Property Organisation (WIPO)
IL-8 antibodies
Grant US-9969800-B2
United States of America
ENGINEERED ANTIBODIES AND OTHER FC-DOMAIN CONTAINING MOLECULES WITH ENHANCED AGONISM AND…
Application WO-2018031258-A1
World Intellectual Property Organisation (WIPO)
Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
Grant US-9890377-B2
United States of America
Heterodimerized polypeptide
Grant US-9890218-B2
United States of America
Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
Grant US-9868948-B2
United States of America
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
Grant US-9828429-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-9803023-B2
United States of America
Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof
Grant US-9796783-B2
United States of America
NON-ANTAGONISTIC ANTIBODIES DIRECTED AGAINST THE ALPHA CHAIN OF THE IL7 RECEPTOR…
Application WO-2017149394-A1
World Intellectual Property Organisation (WIPO)
ANTIBODIES WITH ENHANCED OR SUPPRESSED EFFECTOR FUNCTION
Application EP-3208281-A1
European Patent Office
Optimized Fc variants and methods for their generation
Grant US-9714282-B2
United States of America
ANTIBODY MOLECULES WHICH BIND CD45
Application WO-2017009473-A1
World Intellectual Property Organisation (WIPO)
Compositions and methods for simultaneous bivalent and monovalent co-engagement of…
Grant US-9493578-B2
United States of America
Antibody variants with enhanced complement activity
Grant US-9475881-B2
United States of America
Targeted cytokine for treatment of musculoskeletal diseases
Grant US-9289513-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-9200079-B2
United States of America
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
Grant US-9096651-B2
United States of America
Anti CD37 antibodies
Application US-9078879-B2
United States of America
BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2
Application WO-2015077891-A1
World Intellectual Property Organisation (WIPO)
Modified FC molecules
Grant US-9040041-B2
United States of America
Antigen-binding molecule for promoting disappearance of antigen via FcγRIIB
Application KR-20140130707-A
Republic of Korea
Fc variants with altered binding to FcRn
Grant US-8883973-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-8852586-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-8802820-B2
United States of America
Fc variants having increased affinity for fcyrllc
Grant US-8735545-B2
United States of America
Immunoglobulin Fc polypeptides
Grant US-8679493-B2
United States of America
ANTIBODIES WITH ENHANCED OR SUPPRESSED EFFECTOR FUNCTION
Application EP-2552957-A4
European Patent Office
Fc variants that extend antibody half-life
Grant US-8546543-B2
United States of America
ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA FcγRIIB
Application WO-2013125667-A1
World Intellectual Property Organisation (WIPO)
ANTIBODY ISOFORM ARRAYS AND METHODS THEREOF
Application WO-2013087789-A1
World Intellectual Property Organisation (WIPO)
ANTIBODIES WITH ENHANCED OR SUPPRESSED EFFECTOR FUNCTION
Application EP-2552957-A1
European Patent Office
Fc variants with altered binding to FcRn
Grant US-8367805-B2
United States of America
Antibody variants with enhanced complement activity
Grant US-8362210-B2
United States of America
FC variants with altered binding to FCRN
Grant US-8338574-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-8324351-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-8318907-B2
United States of America
Immunoglobulin insertions, deletions and substitutions
Grant US-8101720-B2
United States of America
Optimized Fc variants and methods for their generation
Grant US-8093357-B2
United States of America
Showing items 101–146